Impact Factor
2.92
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.67
528 total citations
h5-index
21
h5 depth signal
Cited share
53.4%
171 of 320
Total citations
528
Citation footprint
Metric signal
1.57
External metric anchor
Self-citation
15.0%
79 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
840
China
110
Canada
102
Italy
91
Tunisia
64
Citing Fields of Research
Allergies
1,257
Dermatology
343
Immunology
66
Auto-Inflammatory Disorders
55
Pharmacology & Toxicology
29
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
7,651
Articles tracked across the journal lifetime
Indexed publication set
320
171 cited publications
Last 12 months
248
20.7 publications/month
Open access share
10.5%
26 OA publications in the last year
Leading citing country
United States
840 citing publications
Leading citing field
Allergies
1,257 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v15n1, Mar. 2004-
v15n1, Mar. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Allergies
Issuing & Sponsoring Bodies
Contributor
American Contact Dermatitis Society
Contributor
North American Contact Dermatitis Group
Broad Categories
Dermatology
Allergies
MeSH Descriptors
Dermatitis, Atopic
Dermatitis, Contact
Dermatitis, Occupational
Drug Eruptions.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/17103568261496163
Open DOI
Validation of Head and Neck EASI Severity Strata Against vIGA-AD in Atopic Dermatitis
Background: Head-and-neck (H&N) Eczema Area and Severity Index (EASI) sub-scores are increasingly reported, but their clinical interpretation relative to the validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) remain...
02
DOI 10.1177/17103568261499950
Open DOI
In Memoriam: Lasse Kanerva (1943–2026)
03
DOI 10.1177/17103568261497226
Open DOI
Atopic Dermatitis and Emotional and Behavioral Outcomes in Infants and Toddlers: A U.S. Population-Based Study
Background: Infantile atopic dermatitis (AD) is associated with anxiety, depression, and behavioral problems years later. However, its association with early emotional/behavioral signs in infancy and toddlerhood remains underexplored. Ob...
04
DOI 10.1177/17103568261496649
Open DOI
Letter: The Relationship of Insurance Status with Infantile Atopic Dermatitis Severity and Parental Quality of Life
05
DOI 10.1177/17103568261495266
Open DOI
Managing Allergic Contact Dermatitis From N-(Cyclohexylthio) Phthalimide: Identifying CTP-Free Glove Options
06
DOI 10.1177/17103568261492616
Open DOI
Allergens and Marketing Claims of Popular Over-the-Counter Deodorants
Background: Deodorants are a common cause of allergic contact dermatitis and a commonly used product by patients. Most contain known allergens, leaving patients unaware of the risks for adverse events. Objective: Evaluate ingredient alle...
07
DOI 10.1177/17103568261491058
Open DOI
Age-Related Patterns in Anogenital Allergic Contact Dermatitis: A Retrospective Study
Background: Allergic contact dermatitis (ACD), can involve any area of the body. However, the anogenital region remains under-studied and diagnostically challenging. Objective: To investigate the association between age and patch test re...
08
DOI 10.1177/17103568261486176
Open DOI
North American Contact Dermatitis Group Patch Test Results: 2023–2024
Background: Patch testing is the most important diagnostic test for allergic contact dermatitis. Objective: Summarize patch test results from the North American Contact Dermatitis Group (NACDG) of patients tested to a screening series of...
09
DOI 10.1177/17103568261495273
Open DOI
A Case of Follicular Allergic Contact Dermatitis to Isopropyl Alcohol Swabs
10
DOI 10.1177/17103568261468627
Open DOI
Diagnostic Performance of the Lymphocyte Transformation Test and Patch Testing in Delayed Hypersensitivity Drug Reactions
Background: Cutaneous adverse drug reactions (CADRs) occur in 2–5% of inpatients, primarily due to delayed (T-cell-mediated) reactions, such as maculopapular exanthemas (MPEs). The lymphocyte transformation test (LTT) detects drug-specif...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 15, no. 2 (June 2004).
Also issued online.